Feedback / Questions
ALA-101 - Arovella Therap
SPX-101 - Spyryx Biosci
https://www.proactiveinvestors.co.uk/companies/news/1039329/arovella-therapeutics-well-placed-to-advance-inkt-cell-therapy-cancer-treatment-towards-first-in-human-clinical-trials-1039329.html
Jan 25, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next